Prospera Life Sciences Private Limited
About Prospera Life Sciences Private Limited
Data last updated:
Prospera Life Sciences Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2022PTC106894.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nishant Sharma and Ankush.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 400/12 Jacumpura Near Dr Jai Bhagwan, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.68 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹6.93 Lakh (net margin 1%) and EBITDA of ₹9.46 Lakh (EBITDA margin 1.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No. 400/12 Jacumpura Near Dr Jai Bhagwan, Gurgaon, Haryana, India – 122001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Prospera Life Sciences Private Limited
The main business activity of Prospera Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prospera Life Sciences Private Limited FY 2025 filings available
Prospera Life Sciences Private Limited reported revenue of ₹6.68 Cr (up 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Prospera Life Sciences Private Limited
Revenue rose 65% in the latest year. EBITDA rose 53% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Prospera Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹9.46 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.93 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Prospera Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.4% | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prospera Life Sciences are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Prospera Life Sciences Private Limited
Prospera Life Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emmemm Motors India Private Limited | ₹6.73 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Bengaluru, Karnataka, India |
| Zero - D Industries Private Limited | ₹6.71 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Latur, Maharashtra, India |
| Techworks Engineering Private Limited | ₹6.71 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Dumini Air Travels Private Limited | ₹6.7 Cr (FY 2025) | •••• | •••• | -63.0% | •••• | Bangalore, Karnataka, India |
| Such Impex Private Limited | ₹6.69 Cr (FY 2025) | •••• | •••• | -38.0% | •••• | New Delhi, Delhi, India |
| Prospera Life Sciences Private Limited this company | ₹6.68 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Gurgaon, Haryana, India |
| SBKB Agritech Private Limited | ₹6.67 Cr (FY 2025) | •••• | •••• | -79.0% | •••• | Delhi, India |
| Sodhi Car Bazaar Private Limited | ₹6.66 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Ludhiana, Punjab, India |
| Amrita Polytex Pvt Ltd | ₹6.65 Cr (FY 2024) | •••• | •••• | 1592.0% | •••• | Mumbai, Maharashtra, India |
| Grahil Foods Private Limited | ₹6.64 Cr (FY 2024) | •••• | •••• | 73.0% | •••• | Noida, Uttar Pradesh, India |
| G-Nine Tradex Private Limited | ₹6.64 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Prospera Life Sciences by revenue in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Prospera Life Sciences Private Limited
Prospera Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nishant Sharma | Director | 29 Sep 2022 | 4 Years 0 Months | Current |
| Ankush | Director | 29 Sep 2022 | 4 Years 0 Months | Current |
Charges & Borrowings of Prospera Life Sciences Private Limited
Prospera Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Prospera Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Prospera Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prospera Life Sciences Private Limited
Prospera Life Sciences Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ankush was appointed as Director on 29 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Prospera Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Prospera Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prospera Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prospera Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prospera Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prospera Life Sciences Private Limited
Prospera Life Sciences is an active private limited company based in Gurgaon, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2022 (4+ years old) and is registered under CIN U24290HR2022PTC106894.
Prospera Life Sciences reported revenue of ₹6.68 Cr for FY 2025 (up 65% YoY).
Prospera Life Sciences has 2 current directors:
- Nishant Sharma - Director
- Ankush - Director
Prospera Life Sciences reported a net profit of ₹6.93 Lakh (net margin 1%) and EBITDA of ₹9.46 Lakh (EBITDA margin 1.4%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Prospera Life Sciences is U24290HR2022PTC106894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prospera Life Sciences was incorporated on 29 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Prospera Life Sciences by revenue are Emmemm Motors India Private Limited, Zero - D Industries Private Limited, Techworks Engineering Private Limited, Dumini Air Travels Private Limited, Such Impex Private Limited and 5 more, all in the same principal business activity (Wholesale and retail trade and repair of motor vehicles and motorcycles).
Ankush was appointed as Director on 29 Sep 2022. Nishant Sharma was appointed as Director on 29 Sep 2022.
The registered office of Prospera Life Sciences is at H No. 40012 Jacumpura Near Dr Jai Bhagwan, Gurgaon, Haryana, India – 122001.
Prospera Life Sciences has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.
Prospera Life Sciences operates in the pharma industry, in the drug formulation and development segment.